{"id":14113,"date":"2018-05-25T12:00:00","date_gmt":"2018-05-25T10:00:00","guid":{"rendered":"https:\/\/www.fundacionbankinter.org\/noticias\/que-es-la-esperanza-de-vida-saludable\/"},"modified":"2025-12-01T23:29:25","modified_gmt":"2025-12-01T22:29:25","slug":"que-es-la-esperanza-de-vida-saludable","status":"publish","type":"noticias","link":"https:\/\/www.fundacionbankinter.org\/en\/news\/que-es-la-esperanza-de-vida-saludable\/","title":{"rendered":"What is going to be our life expectancy?"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.fundacionbankinter.org\/en\/experts\/aubrey-de-grey\/\"><strong><em>Aubrey de Grey<\/em><\/strong><\/a>, an expert at the <strong>FTF<\/strong>, is very optimistic about increasing human life expectancy. For him, the extension of life expectancy is and &#8220;<em>can only be<\/em>&#8221; a consequence of the extension of life with health and, therefore, what has to be worked on and what the &#8220;<strong>gerontological science<\/strong>&#8221; focuses on is advances in health.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong><em>Aubrey de Grey<\/em><\/strong>\u00a0does not agree on an important point with<a href=\"https:\/\/www.fundacionbankinter.org\/en\/experts\/jay-olshansky\/\">\u00a0<strong><em>Jay Olshansky<\/em><\/strong><\/a>. In his opinion, when talking about a unitary concept called &#8220;aging process&#8221; there is a risk of looking for &#8220;<em>femomatic bullets<\/em>&#8220;; simple strategies that look for a kind of magic method to slow down aging.<\/p>\n\n\n\n<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe loading=\"lazy\" title=\"\u00bfVivir\u00e1 el ser humano eternamente? | Aubrey de Grey\" width=\"500\" height=\"281\" src=\"https:\/\/www.youtube.com\/embed\/aiC2B1_7RoQ?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\n<\/div><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">What, then, would be the right way to approach the problem? For him, you have to resort to a classic war strategy, divide and conquer. It is, in other words, about prioritizing the preventive strategy. &#8220;<em>We must examine, characterize and attack the increase of different types of damage that accumulate in the body, but starting from the basis that what we call damage is a consequence of the accumulation of changes inherent in life; modifications that occur at the cellular and molecular level that the body is willing to tolerate, but only to a certain extent, and that there will come a time when it will not allow them anymore<\/em>,&#8221; he summarizes.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">It is therefore not as unitary an approach as it might seem at first, but it is closer to it than the traditional one of attacking one disease every time. &#8220;<em>We face a lot of problems, but it is, after all, a manageable number of problems<\/em>,&#8221; he emphasizes. Again we speak of intentions rather than realities, because the expert expresses his &#8220;belief&#8221; that in the near future these problems can be solved with medicine.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">These still theoretical interventions would not only serve to help people who reach 80 or 90 years of age biologically healthy, but also for those who get sick at 60 or 70 years of age.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Living longer thanks to science<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><p>Because something that science does seem to have shown is that, although life expectancy changes in different people, the types of damage that accumulate before dying are the same. That is, it gets sick with the same pathologies, although there are those who do it before and those who do it later. &#8220;<em>This is good news, because it means that we should be able to develop rejuvenating therapies that work for everyone, even if they have to be applied sooner, later or more or less frequently<\/em>,&#8221; says the expert <\/p>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">It is again stressed that these interventions are, for the moment, pure theory, although it is recognized that it would be important to establish a time frame. But is it possible to do so? Not even the staunchest proponent of its advent believes it and, in fact, speaks of any date being pointed out being merely speculative. However,&nbsp;<strong><em>De Grey<\/em><\/strong>&nbsp;believes it is positive that each expert in his area formulates the prediction he can, always pointing out, of course, its speculative character. The reason why you have to venture to set a date, even if it is completely unknown, has to do with society&#8217;s perception that, without that time frame, the defeat of aging is science fiction. &#8220;<em>If we let society stay with that fatalistic attitude, we are not only promoting a world in which there are more and more diseases such as Alzheimer&#8217;s, but we will also live a delay of the moment when these therapies reach clinical practice<\/em>,&#8221; says the co-founder of&nbsp;<a href=\"https:\/\/www.sens.org\/\"><strong>SENS<\/strong><\/a>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"> Behind this thought is the important funding required by the medicine of aging and that it must be sought whether the possibility of developing these treatments is 50% in 20 or 30 years &#8211; your personal bet &#8211; or if it can take a century until it is achieved.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The thesis that aging can be treated as an entity with therapies that are being studied and for which there is still no evidence, generates controversy in the scientific community, as was highlighted in the Future Trends Forum of the Bankinter Innovation Foundation.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Evolution of longevity<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Inference taking the hypothesis of this development for granted, there are controversial issues surrounding it. The CEO and co-founder of the company&nbsp;<a href=\"https:\/\/www.aging2.com\/\"><strong>Aging2.0<\/strong><\/a>, and expert of the&nbsp;<strong>FTF<\/strong>,&nbsp;<a href=\"https:\/\/www.fundacionbankinter.org\/en\/experts\/stephen-johnston\/\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>Stephen Johnston<\/strong><\/a>, wonders if this approach \u2013 of which its economic cost has been underlined \u2013 will be something for few or will be an intervention with a broad impact on society. The question is very timely if one takes into account that the medicine that today applies to the elderly is extremely expensive and is restricted to the ability to pay that each one has, especially in societies where social security systems are not especially protective.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><p>For&nbsp;<strong>De Grey<\/strong>, this is not going to happen with preventive medicine of aging, because the main difference with the current one is that, in his opinion, the latter does not work. &#8220;<em>It&#8217;s a medicine that can slightly postpone death, but death occurs in the end<\/em>,&#8221; he says <\/p>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">However, <strong> what would happen if the therapeutic anti-aging intervention worked<\/strong>? Logic dictates that it would allow chronologically ill people born long ago to suddenly be in good health. This would imply a <strong>double saving<\/strong>:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>1.&nbsp;<\/strong>On the one hand, you would stop spending money on therapies that don&#8217;t work, you would save the money you spend on &#8220;keeping sick people alive.&#8221;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>2.&nbsp;<\/strong>For the other, those same people would become or would become productive again.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">&#8220;<em>This makes it very obvious that these therapies, even if they were very expensive, would pay for themselves quickly<\/em>,&#8221; says <strong>De Grey<\/strong>, who defines it as &#8220;<em>economically suicidal from a social perspective<\/em>&#8221; not to make them available to anyone who is old enough to need them completely free of charge.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Although there is speculation about the high price of the still non-existent anti-aging therapies, there is already a treatment that will begin to be tested in a clinical trial and has a low cost. This is the&nbsp;<strong>metformin<\/strong>, a molecule already used in the treatment of diabetes to be tested as an anti-aging drug. Thus, the study&nbsp;<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5943638\/\"><strong>TAME<\/strong><\/a>, led by the specialist of the&nbsp;<a href=\"https:\/\/www.einstein.yu.edu\/\"><strong>Albert Einstein College of Medicine<\/strong><\/a>,&nbsp;<a href=\"https:\/\/www.einstein.yu.edu\/faculty\/484\/nir-barzilai\/\"><strong><em>Nir Barzilai<\/em><\/strong><\/a>&nbsp;in collaboration with the American Federation for Research on Aging ( <a href=\"https:\/\/www.afar.org\/\"><strong>AFAR<\/strong><\/a>), will evaluate this molecule in 3,000 volunteers, who will consume it for six years to see if it also serves to extend life expectancy. &#8220;<em>It will start testing next year and the cost is minimal; if it works, it would be cheap and available to everyone<\/em>,&#8221; says <strong><em>Olshanky<\/em><\/strong>. This expert, however, believes that the fact that something is expensive should not be an obstacle to its pursuit and recalls that many of the key advances in public health of the last 200 years have not been distributed from the beginning in an equal way, including health, water or education,  among others.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In short, although there are scientific disagreements about the possibility of extending life expectancy accompanied by good health, all the actors involved seem to converge on the need to reduce what has been defined as a red zone. &#8220;<em>The divergence is more in the specific mechanisms and the scientific approach to achieve it<\/em>,&#8221; says <strong>Chris Meyer<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Science is undoubtedly working on it and, among other studies, it is worth mentioning the&nbsp;<a href=\"https:\/\/www.icpsr.umich.edu\/icpsrweb\/NACDA\/series\/487\">Long longitudinal survey on Healthy Longevity<\/a>&nbsp;which, carried out in China, is funded by funds from the US National Institutes of Health and evaluates centenarians who have reached that age in good health, &nbsp;<strong>taking into account their genetics, their behavior and life expectancy<\/strong>&nbsp;that could be expected in them, something that will give a lot of light on this science that is still in its infancy and that will help answer the question that everyone asks:&nbsp;<strong> what will our life expectancy be?<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Science is working to prolong our life expectancy.<\/p>\n","protected":false},"featured_media":13925,"template":"","meta":{"_acf_changed":false,"_oaas_summary":"Aubrey de Grey, a leading expert in gerontology, is highly optimistic about increasing human life expectancy through extending healthy life rather than merely prolonging lifespan. He argues that aging should not be seen as a single unified process to be tackled by one \u201cmagic bullet\u201d but rather as a complex accumulation of various types of cellular and molecular damage. His strategy emphasizes a \u201cdivide and conquer\u201d approach, focusing on preventing and repairing these different damages before they become intolerable to the body. This preventive medicine approach aims to maintain biological health well into old age, potentially benefiting not only those who reach 80 or 90 in good health but also individuals who become ill earlier.\n\nWhile these anti-aging interventions remain theoretical, de Grey stresses the importance of setting speculative timelines to combat societal fatalism, which can delay research funding and clinical adoption. The scientific consensus acknowledges that although people age differently, the types of damage leading to diseases like Alzheimer\u2019s are consistent, offering hope for universal rejuvenation therapies. The economic implications are significant; effective anti-aging treatments could reduce healthcare costs by restoring health and productivity, making such therapies economically viable despite initial expenses. Current research includes affordable trials like the TAME study testing metformin\u2019s potential for life extension. Despite ongoing debates, experts agree on the urgent need to reduce the \u201cred zone\u201d of unhealthy aging, with studies worldwide investigating genetics, lifestyle, and longevity to better predict and enhance human lifespan.","_oaas_audio_url":"https:\/\/www.fundacionbankinter.org\/wp-content\/uploads\/2025\/12\/summary-14113-1764628170.mp3"},"categories":[],"class_list":["post-14113","noticias","type-noticias","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>What is going to be our life expectancy?<\/title>\n<meta name=\"description\" content=\"Science is working to prolong our life expectancy.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fundacionbankinter.org\/en\/news\/que-es-la-esperanza-de-vida-saludable\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"What is going to be our life expectancy?\" \/>\n<meta property=\"og:description\" content=\"Science is working to prolong our life expectancy.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fundacionbankinter.org\/en\/news\/que-es-la-esperanza-de-vida-saludable\/\" \/>\n<meta property=\"og:site_name\" content=\"Fundaci\u00f3n Innovaci\u00f3n Bankinter\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/FundacionBankinter\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-01T22:29:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.fundacionbankinter.org\/wp-content\/uploads\/2022\/01\/jon-tyson-FlHdnPO6dlw-unsplash-2-scaled-e1643023976562.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1798\" \/>\n\t<meta property=\"og:image:height\" content=\"1798\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"What is going to be our life expectancy?\" \/>\n<meta name=\"twitter:description\" content=\"Science is working to prolong our life expectancy.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.fundacionbankinter.org\/wp-content\/uploads\/2022\/01\/jon-tyson-FlHdnPO6dlw-unsplash-2-scaled-e1643023976562.jpg\" \/>\n<meta name=\"twitter:site\" content=\"@FundacionBKT\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.fundacionbankinter.org\\\/en\\\/news\\\/que-es-la-esperanza-de-vida-saludable\\\/\",\"url\":\"https:\\\/\\\/www.fundacionbankinter.org\\\/en\\\/news\\\/que-es-la-esperanza-de-vida-saludable\\\/\",\"name\":\"What is going to be our life expectancy?\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.fundacionbankinter.org\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.fundacionbankinter.org\\\/en\\\/news\\\/que-es-la-esperanza-de-vida-saludable\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.fundacionbankinter.org\\\/en\\\/news\\\/que-es-la-esperanza-de-vida-saludable\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.fundacionbankinter.org\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/jon-tyson-FlHdnPO6dlw-unsplash-2-scaled-e1643023976562.jpg\",\"datePublished\":\"2018-05-25T10:00:00+00:00\",\"dateModified\":\"2025-12-01T22:29:25+00:00\",\"description\":\"Science is working to prolong our life expectancy.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.fundacionbankinter.org\\\/en\\\/news\\\/que-es-la-esperanza-de-vida-saludable\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.fundacionbankinter.org\\\/en\\\/news\\\/que-es-la-esperanza-de-vida-saludable\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.fundacionbankinter.org\\\/en\\\/news\\\/que-es-la-esperanza-de-vida-saludable\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.fundacionbankinter.org\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/jon-tyson-FlHdnPO6dlw-unsplash-2-scaled-e1643023976562.jpg\",\"contentUrl\":\"https:\\\/\\\/www.fundacionbankinter.org\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/jon-tyson-FlHdnPO6dlw-unsplash-2-scaled-e1643023976562.jpg\",\"width\":1922,\"height\":2560,\"caption\":\"10 years of Cloud Computing\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.fundacionbankinter.org\\\/en\\\/news\\\/que-es-la-esperanza-de-vida-saludable\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.fundacionbankinter.org\\\/en\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"What is going to be our life expectancy?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.fundacionbankinter.org\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.fundacionbankinter.org\\\/en\\\/\",\"name\":\"Fundaci\u00f3nInnovaci\u00f3nBankinter\",\"description\":\"Una organizaci\u00f3n con la misi\u00f3n de promover la creaci\u00f3n de riqueza en nuestro pa\u00eds a trav\u00e9s de la innovaci\u00f3n y el emprendimiento.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.fundacionbankinter.org\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.fundacionbankinter.org\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.fundacionbankinter.org\\\/en\\\/#organization\",\"name\":\"Fundaci\u00f3n Innovaci\u00f3n Bankinter\",\"url\":\"https:\\\/\\\/www.fundacionbankinter.org\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.fundacionbankinter.org\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.fundacionbankinter.org\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/Logo-Fundacion.jpg\",\"contentUrl\":\"https:\\\/\\\/www.fundacionbankinter.org\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/Logo-Fundacion.jpg\",\"width\":2225,\"height\":1454,\"caption\":\"Fundaci\u00f3n Innovaci\u00f3n Bankinter\"},\"image\":{\"@id\":\"https:\\\/\\\/www.fundacionbankinter.org\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/FundacionBankinter\",\"https:\\\/\\\/x.com\\\/FundacionBKT\",\"https:\\\/\\\/www.instagram.com\\\/fibankinter\\\/?hl=es\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/fundacion-innovaci\u00f3n-bankinter\\\/?viewAsMember=true\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCIBC-qbnAX_-DAH9-_vvLuw\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"What is going to be our life expectancy?","description":"Science is working to prolong our life expectancy.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fundacionbankinter.org\/en\/news\/que-es-la-esperanza-de-vida-saludable\/","og_locale":"en_US","og_type":"article","og_title":"What is going to be our life expectancy?","og_description":"Science is working to prolong our life expectancy.","og_url":"https:\/\/www.fundacionbankinter.org\/en\/news\/que-es-la-esperanza-de-vida-saludable\/","og_site_name":"Fundaci\u00f3n Innovaci\u00f3n Bankinter","article_publisher":"https:\/\/www.facebook.com\/FundacionBankinter","article_modified_time":"2025-12-01T22:29:25+00:00","og_image":[{"width":1798,"height":1798,"url":"https:\/\/www.fundacionbankinter.org\/wp-content\/uploads\/2022\/01\/jon-tyson-FlHdnPO6dlw-unsplash-2-scaled-e1643023976562.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_title":"What is going to be our life expectancy?","twitter_description":"Science is working to prolong our life expectancy.","twitter_image":"https:\/\/www.fundacionbankinter.org\/wp-content\/uploads\/2022\/01\/jon-tyson-FlHdnPO6dlw-unsplash-2-scaled-e1643023976562.jpg","twitter_site":"@FundacionBKT","twitter_misc":{"Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.fundacionbankinter.org\/en\/news\/que-es-la-esperanza-de-vida-saludable\/","url":"https:\/\/www.fundacionbankinter.org\/en\/news\/que-es-la-esperanza-de-vida-saludable\/","name":"What is going to be our life expectancy?","isPartOf":{"@id":"https:\/\/www.fundacionbankinter.org\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.fundacionbankinter.org\/en\/news\/que-es-la-esperanza-de-vida-saludable\/#primaryimage"},"image":{"@id":"https:\/\/www.fundacionbankinter.org\/en\/news\/que-es-la-esperanza-de-vida-saludable\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fundacionbankinter.org\/wp-content\/uploads\/2022\/01\/jon-tyson-FlHdnPO6dlw-unsplash-2-scaled-e1643023976562.jpg","datePublished":"2018-05-25T10:00:00+00:00","dateModified":"2025-12-01T22:29:25+00:00","description":"Science is working to prolong our life expectancy.","breadcrumb":{"@id":"https:\/\/www.fundacionbankinter.org\/en\/news\/que-es-la-esperanza-de-vida-saludable\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fundacionbankinter.org\/en\/news\/que-es-la-esperanza-de-vida-saludable\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fundacionbankinter.org\/en\/news\/que-es-la-esperanza-de-vida-saludable\/#primaryimage","url":"https:\/\/www.fundacionbankinter.org\/wp-content\/uploads\/2022\/01\/jon-tyson-FlHdnPO6dlw-unsplash-2-scaled-e1643023976562.jpg","contentUrl":"https:\/\/www.fundacionbankinter.org\/wp-content\/uploads\/2022\/01\/jon-tyson-FlHdnPO6dlw-unsplash-2-scaled-e1643023976562.jpg","width":1922,"height":2560,"caption":"10 years of Cloud Computing"},{"@type":"BreadcrumbList","@id":"https:\/\/www.fundacionbankinter.org\/en\/news\/que-es-la-esperanza-de-vida-saludable\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"News","item":"https:\/\/www.fundacionbankinter.org\/en\/news\/"},{"@type":"ListItem","position":2,"name":"What is going to be our life expectancy?"}]},{"@type":"WebSite","@id":"https:\/\/www.fundacionbankinter.org\/en\/#website","url":"https:\/\/www.fundacionbankinter.org\/en\/","name":"Fundaci\u00f3nInnovaci\u00f3nBankinter","description":"Una organizaci\u00f3n con la misi\u00f3n de promover la creaci\u00f3n de riqueza en nuestro pa\u00eds a trav\u00e9s de la innovaci\u00f3n y el emprendimiento.","publisher":{"@id":"https:\/\/www.fundacionbankinter.org\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fundacionbankinter.org\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.fundacionbankinter.org\/en\/#organization","name":"Fundaci\u00f3n Innovaci\u00f3n Bankinter","url":"https:\/\/www.fundacionbankinter.org\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fundacionbankinter.org\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.fundacionbankinter.org\/wp-content\/uploads\/2021\/09\/Logo-Fundacion.jpg","contentUrl":"https:\/\/www.fundacionbankinter.org\/wp-content\/uploads\/2021\/09\/Logo-Fundacion.jpg","width":2225,"height":1454,"caption":"Fundaci\u00f3n Innovaci\u00f3n Bankinter"},"image":{"@id":"https:\/\/www.fundacionbankinter.org\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/FundacionBankinter","https:\/\/x.com\/FundacionBKT","https:\/\/www.instagram.com\/fibankinter\/?hl=es","https:\/\/www.linkedin.com\/company\/fundacion-innovaci\u00f3n-bankinter\/?viewAsMember=true","https:\/\/www.youtube.com\/channel\/UCIBC-qbnAX_-DAH9-_vvLuw"]}]}},"_links":{"self":[{"href":"https:\/\/www.fundacionbankinter.org\/en\/wp-json\/wp\/v2\/noticias\/14113","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fundacionbankinter.org\/en\/wp-json\/wp\/v2\/noticias"}],"about":[{"href":"https:\/\/www.fundacionbankinter.org\/en\/wp-json\/wp\/v2\/types\/noticias"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fundacionbankinter.org\/en\/wp-json\/wp\/v2\/media\/13925"}],"wp:attachment":[{"href":"https:\/\/www.fundacionbankinter.org\/en\/wp-json\/wp\/v2\/media?parent=14113"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fundacionbankinter.org\/en\/wp-json\/wp\/v2\/categories?post=14113"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}